Independent Research Shows More Uses for Lantis Laser's OCT Technology


DENVILLE, N.J., July 2, 2008 (PRIME NEWSWIRE) -- Lantis Laser Inc. (Pink Sheets:LLSR) (http://www.lantislaser.com), is drawing attention to the increasing applications of Optical Coherence Tomography (OCT).

In a recently published study in Journal of Endodontics (June 2008) by Shemesh H et al at the Academic Center for Dentistry in Amsterdam, Holland, showing OCT application in root canal therapy for detecting root fractures before filling the canal, it was concluded that OCT is a promising method for non-destructive imaging of the root surfaces. Earlier published research by the same group, showed that OCT could detect perforations and other possible defects that could affect a successful outcome of root canal therapy. Dentists have never been able to obtain this information by any other means.

Lantis Laser has exclusive worldwide rights for OCT technology in the $5 Billion dental equipment industry. The technology, which was developed at MIT, is the next generation in medical imaging following the X-ray, ultrasound, and MRI.

Stan Baron, President & CEO of Lantis, commented that, "The more applications OCT can be used for, the more dentists would find it indispensable and this would, of course, accelerate the rate of adoption of Dental OCT and the market penetration".

Lantis is initially targeting its Dental OCT System for use in the early detection of tooth decay, secondary decay under and around fillings, root surface decay and decay under sealants. However many other applications are surfacing that would indicate that Lantis OCT Dental Imaging System would be deployed in a dental office for many more applications than originally envisaged.

Application in orthodontics have been indicated relating to the detection of early demineralization, the precursor to decay, using OCT. Orthodontic treatment requires patient compliance to achieve optimum levels of oral hygiene, particularly around brackets. OCT can detect early demineralization, a sign that the patient may need special attention to ensure that "white spots" on teeth do not detract from successful treatment. A recent publication by Cosmin Sinescu et al in Int. Soc. Opt Eng. ( May 2008) shoed research to using OCT to examined the outcome of different bracket bonding materials and procedures that could affect stability of bracket retention and minimize failures.

Lantis' OCT Dental Imaging System enables the dentist to do diagnostic imaging, chairside and in real-time. As the power source is light-based, unlike x-ray there is no harmful radiation. Images can be captured at a resolution of to 10 times that of x-ray, enabling early detection of decay and detailed examination of microstructural defects.

About Lantis Laser

Lantis was formed to commercialize the application of novel technologies in the dental industry. The criteria for selected products include competitive edge, exclusivity and large market potential. Lantis is currently in Phase 2 and Phase 3 development, moving through beta systems, product development and application for FDA clearance and plans to launch the OCT Dental Imaging System(TM) in the first quarter of 2009. Lantis has exclusive rights to the application of OCT technology in the field of dentistry under its license Agreements with Lawrence Livermore National Laboratory (exclusive); Lightlab Imaging (non-exclusive) and AXSUN (exclusive). To find out more about Lantis Laser (LLSR: PK), visit www.lantislaser.com

Safe Harbor: Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The company intends that such statements about the Company's future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the safe harbors created thereby. The Company is a development stage company who continues to be dependent upon outside capital to sustain its existence. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results.


 For OCT Updates
 http://octnews.hivefire.com

 For Dental Imaging News
 www.DrBicuspid.com


            

Contact Data